pharmaceutical companies news from FierceHealthcare
News
Price hikes could raise $10 billion in additional income for pharmas
Pharmaceutical companies have been asked to help fund health reform by cutting drug costs $8 billion per year over the next 10 years. But while this sounds good, drugmakers may be taking steps to... Read more...
Reform bill would require pharma disclosures of CME funding
While it's gotten relatively little attention from pundits, provisions within reform bills passing through Congress would demand that pharmaceutical companies disclose how they're spending on... Read more...
Pharmas settle $124M Medicaid fraud suit; Legislators fight for 'critical access' funding for rural hospitals;
> Four pharmaceutical companies--Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals and Ortho McNeil Pharmaceuticals-- have agreed to pay $124 million to resolve claims that... Read more...
CME accreditation body plans exposure of courses violating drugmaker influence rules
To remain certified, doctors must take continuing medical education courses each year. With about half of the $1 billion per year cost of these courses being picked up by pharmaceutical companies,... Read more...
Fight erupts on Hill over attempt to raise pharma contributions to reform
Right now, the White House expects to fund reform with contributions from several major sectors within the healthcare industry. That includes the pharmaceutical giants, who have agreed to a cut of... Read more...
Reform bill now includes pharma, devicemaker disclosure of physician consulting
For years, various legislators have struggled with the issue of doctors' accepting payments from drug and device manufacturers, arguing that such relationships were questionable, at best, and harmful... Read more...
SPOTLIGHT: Aides working on reform have health industry connections
Here's a nice situation: According to political insider newspaper Politico, some of the most powerful aides participating in Senate Finance Committee negotiations on health reform have questionable... Read more...
Study: Some physicians uninformed about approved uses of drugs
It's hard enough making sure the pharmaceutical companies don't find tricky ways to pitch physicians on off-label uses of their drugs. Apparently, that's not the only problem out there with off-label... Read more...
Doctor group challenges limits on pharma-physician relationships
Lately, rules limiting relationships between physicians and pharmaceutical companies have been enacted at a rapid pace. Many doctors have been comfortable with these changes, but some aren't happy.... Read more...
Pharma gets White House nod on banning drug reimportation; State budget crunches push hospitals to cut more staff;
> While President Obama endorsed the practice of reimporting cheaper foreign drugs during his campaign, it seems that pharmaceutical companies have changed his mind. FiercePharma > As if the... Read more...
